| Financial Year |
March 31 2023 |
| Monetary Funds |
445,097,118.29 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,114,618.80 |
| Accounts Receivable |
283,943,773.79 |
| Advances to Suppliers |
7,887,534.38 |
| Other Receivables |
6,957,112.78 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
340,292,398.21 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,364,375.38 |
| Total Current Assets |
1,233,493,175.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,208,146.03 |
| Investment Properties |
41,268,183.53 |
| Fixed Assetes |
270,588,653.14 |
| Under-construction Projects |
340,353,161.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
71,793,935.51 |
| R&D expenses |
-- |
| Goodwill |
1,237,039.38 |
| Long-Term Deferred and Prepaid Expenses |
4,909,120.44 |
| Deferred Income Tax Assets |
21,477,887.46 |
| Other Non-Current Assets |
14,785,095.72 |
| Sub-Total of Non-Current Assets |
858,828,315.72 |
| Total Assets |
2,092,321,491.21 |
| Short-Term Loans |
86,545,604.17 |
| Trading Financial liabilities |
-- |
| Notes Payable |
200,000.00 |
| Accounts Payable |
65,311,961.25 |
| Accounts Received In Advance |
280,559.99 |
| Employee Compensation Payable |
972,020.12 |
| Taxes Payable |
14,486,202.29 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
42,410,440.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,007,966.80 |
| Other Current Liabilities |
2,151,357.16 |
| Sub-Total of Current Liabilities |
240,073,801.37 |
| Long-term Loans |
186,068,750.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
4,522,298.68 |
| Deferred Income Tax Liabilities |
5,057,163.06 |
| Other Non-Current Liabilities |
37,106,404.84 |
| Sub-Total of Non-Current Liabilities |
308,385,616.35 |
| Total Liabilities |
548,459,417.72 |
| Paid-In Capital(Or Share Stock) |
439,391,220.00 |
| Capital Surplus |
253,146,917.55 |
| Surplus Reserve |
65,457,607.00 |
| LESS:Treasury Stock |
6,073,392.00 |
| Undistributed Profits |
773,210,091.30 |
| Minority Stockholder's Interest |
3,558,140.47 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,540,303,933.02 |
| Owner's Equity（Stockholder's Equity） |
1,543,862,073.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,092,321,491.21 |
